Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04250350
Brief Title: Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis (ADore)

First Submitted : January 30, 2020
First Submitted that Met QC Criteria : January 30, 2020
First Posted : January 31, 2020

Last Update Submitted that Met QC Criteria : August 30, 2021
Last Update Posted : September 2, 2021